Senator Warren’s 2026 Bill Aims to Put Private‑Equity Execs Behind Bars for Hospital Deaths

When Steward Health Care filed for bankruptcy last year, the headlines were stark: hospitals closed, thousands of jobs vanished, and entire towns suddenly lost emergency rooms. The chain’s downfall was not a simple market misstep—it was a private‑equity‑driven squeeze that piled debt on the system, sold off the land beneath its facilities, and skimmed fees until the operation could barely stay afloat.

Senator Elizabeth Warren says she’s had enough. In February, she and a coalition of Democratic lawmakers rolled out the Corporate Crimes Against Health Care Act of 2026. For the first time, the bill would turn financial mismanagement that leads to patient deaths into a criminal offense, with potential prison time for the executives pulling the strings.

“Looting hospitals and nursing homes is basically a feature of private‑equity’s playbook,” Warren told reporters. “It’s about time that corporate executives face real legal consequences when they put patients and communities at risk.” Under the proposal, a private‑equity leader could be sentenced to as much as six years behind bars if their decisions are shown to have caused a patient’s death.

The timing feels almost inevitable. Between 2016 and 2021, private‑equity assets swelled by more than 116%, according to testimony from the SEC chair. By 2023, the industry managed roughly $8.2 trillion, a figure that continues to climb. Yet the same growth has left a pile of under‑performing, heavily‑leveraged companies on the books—more than 13,500 across U.S. portfolios, including 1,536 in health care, according to PitchBook data cited by the Guardian.

Those numbers translate into real‑world consequences. Private‑equity‑backed firms were behind the majority of large corporate bankruptcies in 2025 and the first half of 2026, according to the Private Equity Stakeholder Project. In health care, the fallout is especially painful: rural hospitals, non‑profit hospices, and even small dental offices have been snapped up, often saddled with debt that forces cuts to staff, equipment, and, ultimately, patient safety.

Academic research backs up the alarm bells. A study of more than 4.1 million Medicare stays over an 11‑year span found that hospitals acquired by private‑equity investors suffered roughly 25 percent more adverse events than comparable facilities. Central‑line infections rose 38 percent, patient falls jumped 27 percent, and surgical‑site infections doubled. While the same hospitals tended to discharge patients a bit sooner—resulting in a marginally lower in‑hospital mortality rate—the risk of death within 30 days after discharge was unchanged.

Patient experience, too, took a hit. Another analysis showed that after a private‑equity takeover, the share of patients rating their hospital a 9 or 10 on a ten‑point scale fell by 2.4 percentage points, and the gap widened to more than 5 points by the third year.

The proposed law does more than threaten jail time. It would empower state attorneys general to claw back any compensation—salaries, fees, dividends—paid to private‑equity executives in the ten‑year window surrounding a health‑care entity’s financial distress. Those recovered sums could then be hit with civil penalties up to five times the amount seized. Additionally, any health‑care provider that receives federal funding would be required to disclose ownership changes, investor fees, and debt‑to‑earnings ratios, or face fines as high as $5 million. The bill also blocks real‑estate investment trusts that rely on sale‑lease‑back structures from tapping federal health‑care program payments.

Industry groups have pushed back, arguing that private‑equity firms face the same macro‑economic headwinds as any other business and that their capital partners can provide much‑needed lifelines during tough periods. Will Dunham, CEO of the American Investment Council, told the Guardian that “private‑equity‑backed businesses face higher interest rates and economic pressures, but they also have committed investment partners that can keep investing through difficult periods.”

Nevertheless, the bill is riding a wave of bipartisan concern over private‑equity power. Earlier this year, Congress passed a housing measure that limited private‑equity investment in single‑family homes, and several states are already drafting their own health‑care restrictions. With the mid‑term elections looming in November, many expect a surge of oversight measures if the political balance shifts.

Whether Warren’s proposal will survive the Senate’s procedural gauntlet remains to be seen. What’s clear, however, is that the conversation around private‑equity’s role in health care has moved from abstract finance talk to concrete accountability—potentially even criminal accountability—for decisions that, at their worst, can cost a life.